Gordon Stein, CFO of CleanTech Lithium, explains why CTL acquired the 23 Laguna Verde licenses. Watch the video here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
The valuation is this low because IMM is now basically a casino stock. Tim has form looking at everything through rose-tinted spectacles, only to find the storm clouds gather & investors are then promptly struck by lightning. If the FDA approves P3, the share price should rise quite significantly. If it doesn't, the share price will fall like a stone. In the latter case, IMM would soon need further funding (which might not be forthcoming). So worst case scenario, it would simply go bust. Investing here offers little more certainty than betting the house on red.
Cheers for this. The slides are equally as informative for those that do not have the patience to view the video.
Key messages for me are:
1) Outlicensing of Lupuzor TM for lupus (ROW) and CIDP in H1 2023. CIDP should have been outlicensed this year, as this has been mentioned since 2021.
2) Lupuzor TM Phase 3 lupus study commencement in H2 2022
3) FDA/IND submission for CIDP study and orphan drug designation in H1 2023
Though TM pointed out that the current sp reflects a highly discounted valuation (currently < £20m) on a peer comparison & DCF basis. So, 2 comparable AIM biotech companies with Phase 3 asset (valued at £57m & £111m as at 29 July 2022). However IMM's valuation is £16m.
Basically the sp is in the toilet, at historical lows, with most PIs just holding out for the FDA decision. There seems little internal reflection of the responsibility for this, but if the peer comparison is fair then the sp should be 30p+ which reflects the latest research note, though not the recent placing reality.
https://www.investormeetcompany.com/investor/meeting/investor-presentation-146
Lord
I am afraid to mention what Chairman Tim was suggesting for future Lupuzor royalties...$150 m per annum with more from the other Peptide drugs.
Such royalties would value IMMU at over a $1 billion plus.
Meanwhile back on Planet Earth......
Given Tim's track record, I wouldn't believe a word he says. Not saying the FDA won't approve, just that it's still an unknown whatever he might like you to think. Does he really expect us to buy into Lanstead being so naive, they've not even done a risk/reward analysis before stomping up more cash? I mean really.
thanks Dallo. I'll have another look for that recording, it wasn't on the site earlier.
Agreed. TM was positive - “on the brink of something really special” - and contrite about past mistakes. Managed to pick some up at 4.99 and 5.1 this morning, and if it falls to those levels again I may buy more. GLA
I did
Tim very bullish .
See SP moving quickly after FDA confirmation later this month....an absolute certainty if you are to believe.
Reason for fund raising..Lanstead will paying multiples of the £1m it is investing as SP soars according to Tim and with no further dilution.
Also wanted to allow loyal investors to participate at this bargain price to gain on the upside.
Funds to cover overheads for at least 12 months excluding funds from Lanstead and warrants etc.
Main takeaway is the FDA approval is a certainty
and SP set to appreciate strongly after decision allowing IMMU to gain substantially from the Lanstead deal.
There is a recording .
If you believe Tim the sunny uplands are within view.
DYOR
Did anybody attend the Investor's meeting this afternoon? Anything to report? Is there a recording of the meeting available?
I won't add one single penny to this stock.
Bit of a drop in the Bid in the back. Perhaps fishing to catch stop losses before Investor Meeting at noon. Very depressing to be back at historical lows, especially for those who had bought in after the last placing expecting a positive news flow.
You don’t care about buying shares 10% more than you need to lol very smart, were you one of the fools who was slating me for saying a placing was needed before the end of this month, the price will imo drop below 5p once the broker shares are sold as people use leverage, anyway we will see, I won’t be adding any more
I have a feeling this will shoot back up and end the day in green after the investors meeting at 12noon today. Good luck to all...including those who panic sold this morning :)
Lambo22, I don't care about 10%, I'm in this for 100-200%. I sold most of my shares when this was at 9p a few months ago, now just slowly building the position again.
Because you don’t know what quantity you will get via broker option, you might get filled, you might not.
I’m just genuinely interested why people would pay 10% more for shares when they can buy them at 5p in size from SCP
So if investors want to contact their broker, and potentially get filled at 5p, great… PI’s treated the same as institutions… what’s yer problem with that?
Well done Wildetiger, I've noticed you've been making good profit on this share. You are about to do it again. I wish I can do the same but my money is locked in unfortunately.
ATB.
GH.
Wigwammer let’s put it this way, if you can buy shares at 5p via the broker option, who in the right mind would pay more than 5p…. That’s like going into a shop and paying 10% more for the same product as the shop down the road that’s 10% cheaper, if I was going to add to my holding I would do it via the broker option at 5p
Wild tiger can I just ask why you didn’t just phone SCP and buy at 5p instead?
Added 66,000 more at 5.45p, thank you sellers.
An army flipping?! The bid is 5.3p and pittance has been sold. It’s not exactly gold rush time :)
I certainly will be asking him, any investor who wants shares can buy them off SCP at 5p, so no doubt we we see an army of people flipping their 5p placing shares! It stinks
Have you sold again Lambo222, and trying to get other investors to sell at a loss. The placing which you have been reminding us has now been done. All these questions you have, you can ask Tim this afternoon.
GH.
Like a certain person plain for all to see